Dental Pulp Disease
11
0
1
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
9%
1 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (11)
Comparative Evaluation of Three Different Pulpotomy Agents in Primary Molars
Diagnostic Accuracy of Cold, Heat, and Electric Pulp Tests
Post Operative Sensitivity of MTA Obturation
Comparison of Post Cementation Sensitivity Between RMGIC and GIC as Luting Materials in a Randomized Clinical Trial
Neuropeptide Y Regulates Neurogenic Pulp Inflammation
Effect of MTAD on The Outcome of Primary Root Canal Treatment
Manual and Rotatory Instrumentation Pulpectomy in Primary Mandibular Molars
Digitized Assessment for the Survival of Mature Anterior Teeth With Periapical Lesion After One Step Regenerative Approach Using Different Asepsis Maneuvers
Sodium Channel Expression in Human Teeth
Success Rate Evaluation of Miniature Pulpotomy With MTA in Primary Molars
Sodium Hypochlorite Pulpotomies in Primary Molars: Comparison With Conventional 20% Formocresol Pulpotomies